Literature DB >> 3826225

Effects of maternal anemia on cardiac output, systemic oxygen consumption, and regional blood flow in pregnant sheep.

D I Edelstone, M E Paulone, J J Maljovec, M Hagberg.   

Abstract

We measured regional blood flows and cardiac output and calculated regional oxygen deliveries (blood flow X arterial blood oxygen concentration) and systemic oxygen delivery, oxygen extraction, and oxygen consumption as maternal hematocrit was varied randomly between 31% and 8% by exchange transfusion with plasma or packed sheep red blood cells. We observed three patterns of response: In the heart, brain, and adrenal glands, oxygen delivery was constant or nearly constant over the range of hematocrits studied; in the kidneys, splanchnic organs, and uteroplacental tissues, oxygen delivery was a linear function of hematocrit; in the carcass tissues, oxygen delivery decreased slowly as hematocrits were reduced from 31% to 15% and dropped rapidly at hematocrits less than or equal to 15%. Systemic oxygen consumption was maintained at normal levels, despite reductions in hematocrit to about 15%, because oxygen extraction increased as compensation. At lower hematocrits, systemic oxygen consumption fell in association with a metabolic acidemia, suggesting that, with this severity of acute anemia, oxygen supply to some tissues in the pregnant sheep was inadequate for tissue metabolic demands.

Entities:  

Mesh:

Year:  1987        PMID: 3826225     DOI: 10.1016/0002-9378(87)90090-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits].

Authors:  O Habler; J Meier; A Pape; H Kertscho; B Zwissler
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

2.  [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits].

Authors:  O Habler; J Meier; A Pape; H Kertscho; B Zwissler
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.